Jane Street’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Jane Street’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-119,000	Closed	-$11.1M	–	11468
2021 Q4	$11.1M	Buy	119,000 +83,300	+233%	+$5.49M	﹤0.01%	1766
2021 Q3	$2.13M	Buy	35,700 +19,000	+114%	+$1.12M	﹤0.01%	4356
2021 Q2	$1.14M	Buy	16,700 +600	+4%	+$39.1K	﹤0.01%	5557
2021 Q1	$1.12M	Sell	16,100 -13,000	-45%	-$1M	﹤0.01%	5250
2020 Q4	$2.24M	Buy	29,100 +21,300	+273%	+$1.6M	﹤0.01%	3293
2020 Q3	$583K	Sell	7,800 -500	-6%	-$33.3K	﹤0.01%	4924
2020 Q2	$522K	Buy	+8,300	New	+$457K	﹤0.01%	5025
2018 Q2	–	Sell	-12,000	Closed	-$474K	–	5843
2018 Q1	$474K	Buy	+12,000	New	+$467K	﹤0.01%	3517

Jane Street's ARNA Position: Q1 2022 in Review

Jane Street sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 14,334 shares — an estimated $1.33M sold.

Jane Street first reported a position in ARNA in Q2 2013 and held it in 23 quarters. The position peaked at $5.54M in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Jane Street reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Jane Street sold 14,334 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.33M.
Jane Street first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 23 quarters.
Jane Street's Arena Pharmaceuticals Inc position peaked at $5.54M in Q3 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.